期刊文献+

传染性法氏囊病重组亚单位疫苗保存期试验 被引量:4

Experiment in the Conservative Period of Recombinant Subunit Vaccine for Infectious Bursal Disease
下载PDF
导出
摘要 将14日龄SPF鸡分为5组,A、B和C组分别接种保存期为20、340、370d的传染性法氏囊病重组亚单位疫苗,D和E组不接种。35日龄时,对A、B、C、D组的鸡以100倍法氏囊感染剂量的标准强毒株IBDV BC-6/85进行滴鼻。攻毒后第4天,将所有鸡致死,进行剖检,观察法氏囊眼观病变,取法氏囊组织以琼脂免疫扩散试验检测传染性法氏囊病毒抗原。法氏囊未见到明显肿大、变黄或胶冻样渗出物或出血等眼观病变及法氏囊中传染性法氏囊病毒抗原检测阴性判定为受到免疫保护。将各组的试验数据以X^2检验进行统计分析。结果,A、B、C、D组的免疫保护率差别具有统计学意义,A与D组、B与D组、C与D组之间的免疫保护率具有极显著差异。结果表明,在2~8℃保存1年该疫苗的稳定性和免疫原性仍然相当好。 14-day-old chickens with specific pathogen free(SPF)were divided into 5 groups. 3 groups (A, B and C ) were intramuscularly injected with recombinant subunit vaccine that been conserved for 20 days, 340 days and 370 days for infectious bursal disease(IBD) respectively; and chickens of group D and E were not intramuscularly injected. At the age of 35 days chickens of 4 groups (A, B, C and D) were infected with the nose-drop route with standard challenge virulent strain of IBDV BC-6/85 at the dosage of 100 times as much as bursal infectious dose. On 4th day of infection all chickens were killed and the visible pathological changes of bursa Fabricii were examined with the naked eyes. The bursa Fabricii were taken and IBDV antigen was tested in all their bursas with agar gel immune-diffusion test(AGID). Immune protection was evaluated with two judging indexes that remarkable tumescence and xanthochromia or colloidal exudant or hemorrhage were not seen and IBDV antigen was negative in bursa Fabricii. All data were analyzed with x^2 test (Chi-square Test ). The difference of percent of immune protection in 4 groups( A, B, C and D) was statistical significance. The difference of percent of immune protection was very significance between group A and group D, between group B and group D, and between group C and group D. The experimental results showed that the stability and immunogenicity of the vaccine were good when the vaccine was conserved for a year at 2 - 8 %.
出处 《安徽农业科学》 CAS 北大核心 2006年第21期5554-5555,共2页 Journal of Anhui Agricultural Sciences
基金 湖北省科技厅重点科技发展项目(992P0706)
关键词 传染性法氏囊病 基因工程亚单位疫苗 保存期 Infectious bursal disease Recombinant subunit vaccine Conservative period
  • 相关文献

参考文献9

  • 1HASSAN M K,SAIF Y M.Influence of the host system on the pathogenicity,immunogenicity and antigenicity of infectious bursal disease virus[J].Avian Dis,1996,40(3):553-561.
  • 2刘伯华,李健强,刘湘涛,韩雪清,薛登民,赵启祖.传染性法氏囊病病毒X毒株不同代次的致病性及VP_2可变区序列分析[J].中国兽医学报,2001,21(1):1-5. 被引量:4
  • 3BAYLISS C D,PETERS R W,COOK J K,et al.A recombinant fowlpox virus that expresses the VP2 antigen of infectious bursal disease virus induces protection against mortality caused by the virus[J].Arch Virol,1991,120:193-205.
  • 4DARTEIL R,BUBLOT M,LAPLACE E,et al.Herpesvirus of turkey recombinant virus expressing infectious bursal disease virus(IBDV)VP2 immunogen induce protection against an IBDV virulent challenge in chickens[J].Virology,1995,211:481-490.
  • 5TSUKAMOTO K,KOJIMA C,KOMORI Y,et al.Protection of chickens against very virulent infectious bursal disease virus(IBDV)and Marek's disease virus(MDV)with a recombinant MDV expressing IBDV VP2[J].Virology,1999,257:352-362.
  • 6HUANG Z,ELANKUMARAN S,YUNUS A S,et al.A recombinant newcastle disease virus(NDV)expressing VP2 protein of infectious bursal disease virus (IBDV)protects against NDV and IBDV[J].J Viro,2004,78(18):10 054-10 063.
  • 7PITCOVSKI J,GUTTER B,GALLILI G,et al.Development and large-scale use of recombinant VP2 vaccine for the prevention of infectious bursal disease of chickens[J].Vaccine,2003,21:4 736-4 743.
  • 8RONG J,CHENG T,LIU X,et al.Development of recombinant VP2 vaccine for the prevention of infectious bursal disease of chickens[J].Vaccine,2005,23(40):4 844-4 851.
  • 9马斌荣.医学统计学[M].北京:人民卫生出版社,2005:77-96.

二级参考文献2

共引文献12

同被引文献23

  • 1赵怀龙,贾世玉,陈如明.鸡传染性法氏囊病基因工程疫苗研究进展[J].中国生物制品学杂志,2005,18(6):538-540. 被引量:5
  • 2程太平,荣俊,彭本英,曹志刚.接种传染性法氏囊病基因工程重组亚单位油乳剂疫苗的产蛋鸡血清抗体与蛋黄抗体的相关性分析[J].中国畜牧兽医,2006,33(5):48-50. 被引量:1
  • 3程太平,荣俊,孙中杰.传染性法氏囊病重组亚单位疫苗的田间试验[J].吉林畜牧兽医,2007,28(8):8-10. 被引量:2
  • 4马斌荣.医学统计学[M].北京:人民卫生出版社,2005:77-96.
  • 5Pitcovski J, Gutter B, Gallili G, et al. Development and large-scale use of recombinant VP2 vaccine for the prevention of infectious bursal disease of chickens[J]. Vaccine, 2003, 21: 4736-4743.
  • 6Rong J, Cheng T, Liu X, Jiang T, Gu H, Zou G. Development of recombinant VP2 vaccine for the prevention of infectious bursal disease of chickens [J]. Vaccine, 2005, 23 (40):4844-4851.
  • 7Leenaars M, Koedom M A, Hendriksen C F M, Claassen E. Immune responses and side effects of five different oil-based adjuvants in mice[J]. Veterinary Immunology and Immunopathology 1998; 61:291-304.
  • 8Azad A A, Jagadish M N, Brown M A, et al. Deletion mapping and expression in Eseheriehia eoli of the large genomic segment of birnavirus [J]. Virology, 1987, 161: 145-152.
  • 9Becht H, Müller H, Müller H K. Comparative studies on structural and antigenic properties of two serotypes infectious bursal disease virus [J]. J Gen Virol, 1988, 69:631 -640.
  • 10Omar A R, Kim C L, Bejo M H, et al. Efficacy of VP2 protein expressed in E. coli for protection against highly virulent infectious bursal disease virus [J]. J Vet Sci, 2006, 7 (3): 241 -247.

引证文献4

二级引证文献4

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部